Experienced in Peripheral T-Cell Lymphoma

Wenyang Y. Huang

Chinese Academy Of Medical Sciences & Peking Union Medical College, 
Tianjin, CN 
Experienced in Peripheral T-Cell Lymphoma
Chinese Academy Of Medical Sciences & Peking Union Medical College, 
Tianjin, CN 
OverviewLocationsClinical Research

Overview

Wenyang Huang practices in Tianjin, China. Huang is rated as an Experienced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Non-Hodgkin Lymphoma, Multiple Myeloma, Waldenstrom Macroglobulinemia, Splenic Neoplasm, and Bone Marrow Transplant.

Their clinical research consists of co-authoring 64 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Peripheral T-Cell Lymphoma.

Locations

Chinese Academy Of Medical Sciences & Peking Union Medical College, Tianjin, China
Other Locations
Beijing, 100044, China
300020, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Observational, Non-interventional, Multicenter Study Aimed at Collecting Prospective Data Related to Study Safety and Effectiveness in Real Clinical Practice in Patients With CD30+ Lymphoma (BRAVE Study)
Observational, Non-interventional, Multicenter Study Aimed at Collecting Prospective Data Related to Study Safety and Effectiveness in Real Clinical Practice in Patients With CD30+ Lymphoma (BRAVE Study)
Enrollment Status: Active_not_recruiting
Publish Date: January 27, 2025
Intervention Type: Other

64 Total Publications

Total tumor apparent diffusion coefficient histogram analysis of whole-body DWI-MRI for prognostic stratification in patients with R-ISS stage II multiple myeloma.
Total tumor apparent diffusion coefficient histogram analysis of whole-body DWI-MRI for prognostic stratification in patients with R-ISS stage II multiple myeloma.
Journal: Magnetic resonance imaging
Published: June 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Huang's expertise for a condition
ConditionClose
      View All 19 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile